Hypoxia-inducible factor 1-alpha (HIF-1α) translation pathway (HIF-1α translation pathway)

The Hypoxia-inducible factor 1-alpha (HIF-1α) translation pathway is a critical regulatory mechanism that controls the rate at which HIF-1α protein is synthesized from its mRNA. While HIF-1α is primarily known for its oxygen-dependent degradation via the VHL-proteasome pathway, its translation is a major oxygen-independent control point regulated by growth factor signaling, specifically the PI3K/Akt/mTOR and MAPK/ERK pathways [Source: PubMed PMID: 21169515]. In many cancers, these pathways are constitutively active due to mutations, leading to an overabundance of HIF-1α protein even under normoxic conditions, a state known as pseudohypoxia [Source: Nature Reviews Cancer, 2003]. This elevated HIF-1α drives the expression of genes essential for tumor survival, including those for angiogenesis (VEGF), glucose transport (GLUT1), and pH regulation (CAIX) [Source: UniProt Q16665]. Therapeutic strategies targeting this pathway include mTOR inhibitors like Everolimus and small molecules like Digoxin or PX-478, which aim to reduce HIF-1α protein levels to inhibit tumor growth and vascularization [Source: PNAS, 2008]. However, targeting this central signaling node can lead to systemic safety concerns such as immunosuppression and metabolic disturbances [Source: Journal of Clinical Oncology, 2009].

Other names

HIF-1α protein synthesisHIF1A translation regulationPI3K/Akt/mTOR/HIF-1α axismTOR-mediated HIF-1α regulation

Inhibition of HIF-1α protein synthesis through modulation of the PI3K/Akt/mTOR axis or direct mRNA interference [Source: Nature Reviews Cancer, 2003].